RReeff..

Frn: Till: rende: Datum: Kristina Johansson fr Representationen Bryssel DL UM Bryssel Rep M Milj; Alexander Meijer; Jeanette B Lund VB: European Business Intelligence | Weekly Highlights | 13 February 2024 den 13 februari 2024 14:11:45 Frn: European Business Intelligence <x@x.x> Skickat: den 13 februari 2024 08:02 Till: Representationen Bryssel <x.x@x.x> mne: European Business Intelligence | Weekly Highlights | 13 February 2024 Show message in browser 13 FEBRUARY 2024 Clean Energy Summit: 18 March 2024 As the EU aims to triple renewable energy and double energy efficiency by 2030, #CES2024 serves as a crucial forum for policy-makers and industry leaders to address climate challenges, emphasizing the Paris Agreement principles and fostering collaboration for a just and inclusive transition.

Helsinki, 15 April 2024 1 (2) D(2024)0332 Conseiller adjoint Secrtaire de la commission de l'Energie, de l'Environnement et du Climat Chambre des reprsentants de Belgique Palais de la Nation, B-1008 Bruxelles Sent by email only: dekamer.be Subject: Dear DOC 55 3791 - PFAS - Schriftelijk adviesaanvraag/ Demande d'avis crit , Thank you for reaching out to the European Chemical Agency and for sharing the proposed resolution of the Belgian Parliament to address exposure and pollution of PFAS with us.

Ref.

Document details Document title: EN: Meeting with the Capital Region of Denmark's environmental unit 29 or 30 May Document number: 23/24454-22 Document ID: Click or tap here to enter text.

Executive Summary Biopharmaceuticals are vital for medicine and have advantages over synthetic drugs, including targeting specific molecules and causing fewer side effects.

Participants DG GROW: Ref.

ROW) 2016 6:30 PM .

Document 19 From: Sent: To: Subject: Attachments: Ref.

E Pyo 10.

o ie 78% 156 Experinent to.: Conducted ats Dates Conducted: Conducted By: 20 bay Percutaneous Absorption Study 7 with re-s9 in Albino Rabbits 097980633 SRStia.kfeertTyaLuaE,bvoaWrliautnaontreiisoeonsr,sLaIbnocr.atory October 24, 1979 to December 18, 1979 a ooi %. bo oanel, 5 3 Bite RStauvdaynceDdirTecotxoircologist Reviewed By: der mKFoInl..

. 7-394" 28 Day Percutaneous Absorption Study | -.

spf Sa {N773 2per MR 54374 UNITED STATES ENVIRONMENTAL PROTECTION AGENeY AR226_ 1093 WASHINGTON, D.C. 20460 AR 2E np Dear Interested Party: On March 28, 2002, EPA made available copies in PDF file format (389KB)ofthe Draft aHnwasazsraaermdtehAntststeiDsssimdieoincotunmOefonPftertifnlcEulPourdAoeodfcatenaneroioocrfAPcionildhlue(tPitFoonOxAPa)rpepAveenandrtiiInotsgnSoaannltdsp,Tagoperwea8p.aireEsdPecbAtyihotanhse2bR0iescokfomtehe document, "Production of PFOA and its Salts."

AR 226 110/ `TOXIKON FINAL REPORT: 01-7019-G1 I CHO/HGPRT FORWARD MUTATION ASSAY - ISO (T-6889.7) DeviAuStadhhour, PhD